These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 7679745)

  • 21. Stability of RNA virus attenuation approaches.
    Kenney JL; Volk SM; Pandya J; Wang E; Liang X; Weaver SC
    Vaccine; 2011 Mar; 29(12):2230-4. PubMed ID: 21288800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant vaccinia/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins.
    Kinney RM; Esposito JJ; Johnson BJ; Roehrig JT; Mathews JH; Barrett AD; Trent DW
    J Gen Virol; 1988 Dec; 69 ( Pt 12)():3005-13. PubMed ID: 2462013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety.
    Guerbois M; Volkova E; Forrester NL; Rossi SL; Frolov I; Weaver SC
    PLoS Negl Trop Dis; 2013; 7(5):e2197. PubMed ID: 23675542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular evidence for the origin of the widespread Venezuelan equine encephalitis epizootic of 1969 to 1972.
    Kinney RM; Tsuchiya KR; Sneider JM; Trent DW
    J Gen Virol; 1992 Dec; 73 ( Pt 12)():3301-5. PubMed ID: 1469368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone.
    Davis NL; Powell N; Greenwald GF; Willis LV; Johnson BJ; Smith JF; Johnston RE
    Virology; 1991 Jul; 183(1):20-31. PubMed ID: 2053280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
    Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
    Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus.
    Brault AC; Powers AM; Holmes EC; Woelk CH; Weaver SC
    J Virol; 2002 Feb; 76(4):1718-30. PubMed ID: 11799167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5' noncoding region and glycoproteins.
    Spotts DR; Reich RM; Kalkhan MA; Kinney RM; Roehrig JT
    J Virol; 1998 Dec; 72(12):10286-91. PubMed ID: 9811777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine.
    Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
    Vaccine; 1995; 13(15):1411-20. PubMed ID: 8578818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody to the E3 glycoprotein protects mice against lethal venezuelan equine encephalitis virus infection.
    Parker MD; Buckley MJ; Melanson VR; Glass PJ; Norwood D; Hart MK
    J Virol; 2010 Dec; 84(24):12683-90. PubMed ID: 20926570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.
    Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE
    Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
    Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC
    Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection.
    Turell MJ; Parker MD
    Am J Trop Med Hyg; 2008 Feb; 78(2):328-32. PubMed ID: 18256440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
    Phillpotts RJ; Lescott TL; Jacobs SC
    Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic peptides of the E2 glycoprotein of Venezuelan equine encephalomyelitis virus. II. Antibody to the amino terminus protects animals by limiting viral replication.
    Hunt AR; Short WA; Johnson AJ; Bolin RA; Roehrig JT
    Virology; 1991 Nov; 185(1):281-90. PubMed ID: 1718085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epitope specificity and protective activity of monoclonal antibodies to Venezuelan equine encephalomyelitis virus].
    Shpilevaia MV; Kush AA; Razumov IA; Arkhipov VN; Tsilinskiĭ IaIa; Loktev VB
    Vopr Virusol; 1995; 40(2):82-5. PubMed ID: 7539195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The immunity generated in white rats vaccinated with strains of the Venezuelan equine encephalomyelitis virus].
    Moshkov SP; Grabareva LP; Moshkov AE; Gaĭdamovich SIa
    Vopr Virusol; 1991; 36(5):417-9. PubMed ID: 1803778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1.
    Davis NL; Brown KW; Greenwald GF; Zajac AJ; Zacny VL; Smith JF; Johnston RE
    Virology; 1995 Sep; 212(1):102-10. PubMed ID: 7676619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge.
    Tretyakova I; Plante KS; Rossi SL; Lawrence WS; Peel JE; Gudjohnsen S; Wang E; Mirchandani D; Tibbens A; Lamichhane TN; Lukashevich IS; Comer JE; Weaver SC; Pushko P
    Vaccine; 2020 Apr; 38(17):3378-3386. PubMed ID: 32085953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunochemical and oligonucleotide fingerprint analyses of Venezuelan equine encephalomyelitis complex viruses.
    Trent DW; Clewley JP; France JK; Bishop DH
    J Gen Virol; 1979 May; 43(2):365-81. PubMed ID: 90115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.